Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
SGD Pharma
SGD Pharma
Activities:
Packaging
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Manufacturing
SGD Pharma successfully trials hydrogen burners at its Saint-Quentin-Lamotte
SGD Pharma’s decarbonisation roadmap aims to reduce CO2 emissions from 2020 by 35% in 2030 and by 65% in 2040
Packaging
SGD Pharma awarded 2024 gold EcoVadis rating
SGD Pharma’s sustainability rating of 77 puts the business in the 98th percentile for manufacturers of glass and glass products
Drug Delivery
SGD Pharma introduces its new range of Type I tubular vials
SGD partner with Corning to announce its new range of type I injectable vials in tubular glass with an added external low-friction coating
Packaging
SGD Pharma expands capacity for siliconised glass vials with new production lines
SGD Pharma announces the opening of a new siliconisation operation at its state-of-the-art Saint-Quentin Lamotte (SQLM) plant
Media
SGD Pharma announces the appointment of Fabio Invernizzi, General Manager West Business Unit
The BU West includes SGD Pharma’s commercial activities for MEA, North and South America and our manufacturing footprint in Europe
Packaging
SGD Pharma defines 2024 growth strategy as it strives for market leadership
SGD Pharma announces its goal to become the global market leader in primary pharmaceutical glass packaging
Sustainability
SGD Pharma commits to near-term science-based targets initiative as part of sustainability drive
SGD Pharma announces its commitment to company wide emissions reductions as part of its decarbonisation strategy by joining the Science Based Targets initiative (SBTi)
Subscribe now